Interventional and synthetic therapy of advanced hepatocellular carcinoma.
- Author:
Xicai CAO
1
;
Nengshu HE
;
Jianzhong SUN
;
Song WANG
;
Xunming JI
;
Hailun FAN
;
Jinsheng WANG
;
Changlin ZHANG
;
Jianguo YANG
;
Tiwen LU
;
Jianhua LI
;
Guoxin ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Carcinoma, Hepatocellular; mortality; therapy; Catheters, Indwelling; Female; Humans; Liver Neoplasms; mortality; therapy; Male; Middle Aged; Survival Rate
- From: Chinese Medical Journal 2002;115(12):1883-1885
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo evaluate the clinical efficacy of interventional therapy in the treatment of hepatocellular carcinoma (HCC).
METHODSThirty-three patients with HCC were synthetically treated by systematic measures. Among them, percutaneous port-catheter system (PCS) implantation via the femoral artery was performed in 21 cases. Patients with haemorrhage were treated with prothrombin complex concentrate and fibroraas, and patients with hepatic encephalopathy by branched-chain amino acids and arginine.
RESULTSAll indwelling catheters of PCS were patent and no catheter tip dislocations were observed. Of 33 patients with advanced HCC, the mean survival rate was 20.1 months and 12 (36%) patients survived more than 2 years.
CONCLUSIONPatients with advanced HCC were treated by synthetic measures. Survival was prolonged, quality of life was improved significantly, and the effectiveness of interventional therapy was further improved.
